Veeva Vault CDMS Selected by Idorsia to Modernize Clinical Data Management

Rhea-AI Summary

Veeva Systems announced that Idorsia Pharmaceuticals has expanded its use of the Veeva Vault Clinical Suite to include Vault CDMS for electronic data capture (EDC) and coding. This collaboration allows Idorsia to speed up its clinical trials by utilizing a modern data management system to enhance study execution and management. The cloud-based Vault CDMS will enable Idorsia's clinical teams to independently build studies and make mid-study amendments efficiently, streamlining trial content and data management.

Positive

• Idorsia expands its partnership with Veeva, enhancing clinical trial efficiency.
• Vault CDMS allows Idorsia to independently build studies and manage data seamlessly.
• The collaboration aims to accelerate the execution of clinical trials.

Negative

• None.

PLEASANTON, Calif., Feb. 15, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Idorsia Pharmaceuticals Ltd (SIX: IDIA) has expanded its use of Veeva Vault Clinical Suite applications to include Veeva Vault CDMS for electronic data capture (EDC) and coding. Idorsia is focused on the discovery, development, and commercialization of innovative therapies and needed a modern data management system to support the in-house execution of studies. Vault CDMS delivers an advanced cloud application suite that will enable Idorsia to accelerate study builds and speed trial execution.

"With the growing complexity of trial design and rise of clinical data sources, a next-generation clinical data management system is critical," said Vincent Rolland, associate director, data management programming at Idorsia. "We're excited to grow our partnership with Veeva to bring greater speed and agility to our clinical trials."

Based in Switzerland, Idorsia is a fast-growing biopharmaceutical company with a broad portfolio of novel drugs in its pipeline. The company is shifting from outsourced clinical data management to an in-house model and required flexible cloud technology that equips its team to build and maintain studies across a wide range of products. With Vault CDMS, Idorsia's clinical teams will have the capabilities to build studies independently, make mid-study amendments without data migration, and accelerate data cleaning and review.

"Idorsia is a visionary company adopting digital systems to advance data management," said Richard Young, vice president, strategy, Veeva Vault CDMS. "As a trusted partner, we're proud to support their clinical systems strategy with modern applications that can keep up with the pace and complexity of today's studies."

Vault CDMS is part of Vault Clinical Suite, the industry's first cloud platform that unifies clinical data management and clinical operations. In addition to selecting Vault CDMS, Idorsia uses Veeva Vault CTMS and Veeva Vault eTMF to manage trial content and data on a single cloud platform. Together, these Vault Clinical Suite applications will streamline execution and enable seamless information sharing across trials.  

Additional Information
For more on Veeva Vault CDMS, visit: veeva.com/VaultCDMS 
Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems 
Follow @veevasystems on Twitter: twitter.com/veevasystems 

About Idorsia
Idorsia Ltd is reaching out for more – We have more ideas, we see more opportunities, and we want to help more patients. In order to achieve this, we will develop Idorsia into a leading biopharmaceutical company, with a strong scientific core.

Headquartered near Basel, Switzerland – a European biotech-hub – Idorsia is specialized in the discovery, development, and commercialization of small molecules to transform the horizon of therapeutic options. Idorsia has a broad portfolio of innovative drugs in the pipeline, an experienced team of professionals covering all disciplines from bench to bedside, state-of-the-art facilities, and a strong balance sheet – the ideal constellation to translate R&D efforts into business success.

Idorsia was listed on the SIX Swiss Exchange (ticker symbol: IDIA) in June 2017 and has over 1000 highly qualified specialists dedicated to realizing our ambitious targets.

About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.

Contact:

Deivis Mercado
Veeva Systems
925-226-8821
deivis.mercado@veeva.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/veeva-vault-cdms-selected-by-idorsia-to-modernize-clinical-data-management-301482295.html

SOURCE Veeva Systems

FAQ

What is Veeva Vault CDMS and how does it benefit Idorsia?

Veeva Vault CDMS is a cloud-based clinical data management system that enables Idorsia to speed up study builds and enhance trial execution through advanced data management capabilities.

Why did Idorsia choose to expand its use of Veeva's applications?

Idorsia shifted to an in-house clinical data management model to better manage its studies and streamline operations using Veeva's modern cloud technology.

How will the partnership between Veeva and Idorsia impact future clinical trials?

The partnership is expected to improve the speed and agility of Idorsia's clinical trials, allowing for faster execution and information sharing across trials.

When was the partnership expansion between Veeva and Idorsia announced?

The expansion of the partnership was announced on February 15, 2022.